These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 2575468

  • 1. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
    Marcocci C, Vitti P, Lopez G, Santini F, Mammoli C, Fenzi GF, Pinchera A.
    Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
    [Abstract] [Full Text] [Related]

  • 2. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.
    Marcocci C, Valente WA, Pinchera A, Aloj SM, Kohn LD, Grollman EF.
    J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493
    [Abstract] [Full Text] [Related]

  • 3. Use of FRTL-5 for the study of thyroid antibodies involved in goitrogenesis.
    Vitti P, Chiovato L, Tonacchera M, Bendinelli G, Mammoli C, Capaccioli A, Giachetti M, Pinchera A.
    Thyroidology; 1992 Apr; 4(1):49-51. PubMed ID: 1284334
    [Abstract] [Full Text] [Related]

  • 4. Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.
    Zakarija M, Jin S, McKenzie JM.
    J Clin Invest; 1988 Mar; 81(3):879-84. PubMed ID: 2893811
    [Abstract] [Full Text] [Related]

  • 5. Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor.
    Macchia E, Concetti R, Carone G, Borgoni F, Fenzi GF, Pinchera A.
    Clin Endocrinol (Oxf); 1988 Feb; 28(2):147-56. PubMed ID: 2901922
    [Abstract] [Full Text] [Related]

  • 6. Stimulated iodide uptake in FRTL-5 cells preincubated with Graves' immunoglobulins in NaCl-free medium: a sensitive assay for thyroid-stimulating antibodies.
    Hidaka A, Kasagi K, Takeuchi R, Iida Y, Misaki T, Grollman EF, Konishi J.
    Thyroid; 1994 Feb; 4(1):31-6. PubMed ID: 7914446
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
    Sato K, Yamazaki K, Yamada E, Kanaji Y, Miura M, Obara T.
    Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
    [Abstract] [Full Text] [Related]

  • 8. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
    Leedman PJ, Frauman AG, Colman PG, Michelangeli VP.
    Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
    [Abstract] [Full Text] [Related]

  • 9. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
    Vitti P, Elisei R, Tonacchera M, Chiovato L, Mancusi F, Rago T, Mammoli C, Ludgate M, Vassart G, Pinchera A.
    J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
    [Abstract] [Full Text] [Related]

  • 10. Measurement of thyroid stimulating immunoglobulins in a new cell line transfected with a functional human TSH receptor (JPO9 cells), compared with an assay using FRTL-5 cells.
    Michelangeli VP, Munro DS, Poon CW, Frauman AG, Colman PG.
    Clin Endocrinol (Oxf); 1994 May; 40(5):645-52. PubMed ID: 7912172
    [Abstract] [Full Text] [Related]

  • 11. Failure to detect thyroid growth-promoting activity in immunoglobulin G of patients with endemic goiter.
    Vitti P, Chiovato L, Tonacchera M, Bendinelli G, Mammoli C, Capaccioli A, Fiore E, Pretell E, Pinchera A.
    J Clin Endocrinol Metab; 1994 May; 78(5):1020-5. PubMed ID: 7909816
    [Abstract] [Full Text] [Related]

  • 12. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
    Vitti P, Rotella CM, Valente WA, Cohen J, Aloj SM, Laccetti P, Ambesi-Impiombato FS, Grollman EF, Pinchera A, Toccafondi R, Kohn LD.
    J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Activity of thyroid stimulating antibody and thyroid stimulation blocking antibody determined by radioiodine uptake into FRTL-5 cells.
    Yoshikawa N, Nishikawa M, Horimoto M, Uno C, Taniguchi N, Inada M.
    Endocrinol Jpn; 1989 Feb; 36(1):55-63. PubMed ID: 2567231
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
    Tamaki H, Amino N, Iwatani Y, Tachi J, Kimura M, Mitsuda N, Ichihara K, Tanizawa O, Miyai K.
    Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
    [Abstract] [Full Text] [Related]

  • 17. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
    Tamaki H, Amino N, Aozasa M, Mori M, Tanizawa O, Miyai K.
    J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
    [Abstract] [Full Text] [Related]

  • 18. Measurement of TSAb directly in serum using FRTL-5 cells.
    Vitti P, Chiovato L, Lopez G, Lombardi A, Santini F, Mammoli C, Bassi P, Gryczynska M, Schipani E, Tosti-Balducci M.
    J Endocrinol Invest; 1988 Apr; 11(4):313-7. PubMed ID: 2900851
    [Abstract] [Full Text] [Related]

  • 19. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
    Bliddal H, Bech K, Siersbaek-Nielsen K, Friis T.
    J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399
    [Abstract] [Full Text] [Related]

  • 20. A sensitive method for assaying thyroid stimulating immunoglobulins of Graves' disease: use of the guanyl nucleotide-amplified thyroid adenylate cyclase assay.
    Macchia E, Carayon P, Fenzi GF, Lissitzky S, Pinchera A.
    Acta Endocrinol (Copenh); 1983 Jul; 103(3):345-51. PubMed ID: 6688318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.